Administration of first dose of SARS-CoV-2 mRNA vaccine
Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
procedure
Supplier: international · SCTID 1144997007
Also known as (14)
- Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid
- First 2019 novel coronavirus mRNA immunisation
- First 2019 novel coronavirus mRNA immunization
- First 2019 novel coronavirus mRNA vaccination
- First 2019-nCoV mRNA immunisation
- First 2019-nCoV mRNA immunization
- First 2019-nCoV mRNA vaccination
- First COVID-19 mRNA immunisation
- First COVID-19 mRNA immunization
- First COVID-19 mRNA vaccination
- First SARS-CoV-2 mRNA immunisation
- First SARS-CoV-2 mRNA immunization
- First SARS-CoV-2 mRNA vaccination
- First severe acute respiratory syndrome coronavirus 2 mRNA vaccination